Curebase
Curebase is an AI-native eClinical platform company serving pharma, biotech, CRO, and MedTech sponsors with integrated ePRO/eCOA, eConsent, EDC, recruitment, and engagement tools, plus a free Sitebase tier for research sites.
- Company typePrivate
- Founded2017
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Curebase does
Curebase is a privately held clinical trial technology company founded in 2017 and headquartered in San Francisco. It sells an AI-native, cloud-native eClinical platform covering the full trial lifecycle—ePRO/eCOA, eConsent, Electronic Data Capture (EDC), patient recruitment, and participant engagement—built on a single structured database with one codebase and one data model. The company differentiates through proprietary AI features embedded natively into the platform: eCOA Vigilance uses machine learning on behavioral metadata to predict participant non-compliance before surveys are missed; Hope is a conversational voice AI agent for multilingual patient outreach, scheduling, and in-visit data capture; and Curebase Recruit applies AI to dynamic pre-screening and channel ROI tracking. Sitebase, a wholly-owned sub-brand, distributes free CTMS, eISF, eSource, and a Voice AI Receptionist to research sites, creating a two-sided adoption model where site stickiness drives sponsor demand.
The business operates a sales-led, enterprise go-to-market targeting pharma sponsors, biotechs, contract research organizations (CROs), and MedTech companies, with modular subscription pricing for the paid Curebase eClinical Platform and a freemium tier (Sitebase) for sites. The company cites a roster including Walgreens, Krystal Biotech, Premier Research, CellMax Life, Gilead Sciences (strategic investor from the Series B), and MedTech firms such as Madorra, Praeventix, ROSE Diagnostics, and Nectero Therapeutics. Revenue is generated through multi-year study subscriptions priced by capabilities deployed and study scale; pricing is not publicly disclosed. The platform holds SOC 2 Type II, GDPR, 21 CFR Part 11, and EU-U.S. Data Privacy Framework certifications, supporting global deployments including North America and Europe. The company has raised $57.6M in total venture funding ($15M Series A in 2021, $40M Series B in 2022 led by Industry Ventures with Gilead Sciences), employs 100-200 people, and has expanded its executive bench in 2025-2026 with hires including a CCO, VP Operations & Strategy, VP Engineering & Product, and Head of AI.
Curebase firmographics
Firmographics- Name
- Curebase
- Legal name
- Curebase, Inc.
- Website
- https://curebase.ai
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Curebase is an AI-native eClinical platform company serving pharma, biotech, CRO, and MedTech sponsors with integrated ePRO/eCOA, eConsent, EDC, recruitment, and engagement tools, plus a free Sitebase tier for research sites.
- Ownership category
- akta.pro rank
Curebase industry classification
Industry- Product category
- eClinical Platform / Clinical Trial Technology
- NAICS
- Computer Systems Design and Related Services (54151), Scientific Research and Development Services (5417)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industries
- Electronic Data Capture (EDC) Platforms (HLACAOAA), Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)
Keywords
Where Curebase is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Curebase business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Curebase eClinical Platform (Paid Subscription): Modular, paid end-to-end eClinical platform subscription for sponsors and CROs. Customers pay for access to ePRO/eCOA, eConsent, EDC, recruitment, participant engagement, and AI capabilities. Pricing is tiered by capabilities deployed and study scale. Fully-loaded quotes include implementation, training, and ongoing support.
- Sitebase (Free Tier): Free core CTMS, eISF, and eSource technology for research sites. Sitebase is provided at no cost to reduce site-level friction and drive sponsor adoption, acting as a customer acquisition and retention mechanism for the paid sponsor platform.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Modular platform with configurable capabilities |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
Curebase product offering
Product offeringCore offering
Curebase provides a paid, end-to-end AI-native eClinical platform that helps clinical trial sponsors, CROs, biotechs, and MedTech companies launch studies faster, capture higher-quality data, and improve participant engagement across the full trial lifecycle (ePRO/eCOA, eConsent, EDC, recruitment, and engagement). The company also offers Sitebase, a free eClinical suite providing CTMS, eISF, and eSource technology to research sites to reduce administrative burden and drive bottom-up platform adoption.
Product overview
Curebase offers a unified, AI-native eClinical platform that combines ePRO/eCOA, eConsent, Electronic Data Capture (EDC), Patient Recruitment (Curebase Recruit), Patient Engagement, Site Management (Sitebase), and AI capabilities (Hope voice agent, eCOA Vigilance) in a single structured system. The platform is designed for sponsors, CROs, biotechs, MedTech companies, and research sites. Sitebase provides free CTMS, eISF, and eSource technology for research sites, while the paid Curebase eClinical Platform covers the full trial lifecycle for sponsors and CROs.
Differentiator
Problem solved
Functional benefit
Brands
- Sitebase: Free eClinical suite built specifically for research sites. Sitebase gives sites access to core eClinical tools including CTMS, eISF, and eSource at no cost, reducing administrative burden on site staff and improving data quality.
Products and services
- Curebase eClinical Platform Paid end-to-end AI-native eClinical platform for sponsors, CROs, biotechs, and MedTech companies that integrates ePRO/eCOA, eConsent, EDC, recruitment, engagement, and AI capabilities in a single structured system. Designed to help trial teams launch studies faster, capture cleaner data, and improve participant engagement across the full trial lifecycle.
- Sitebase Free eClinical suite built specifically for research sites, providing access to core eClinical tools including CTMS, Investigator Site Files (eISF), and eSource at no cost. Reduces administrative burden on site staff, improves data quality at the point of collection, and removes financial barriers to activating community research locations.
Quantifiable outcome
- Studies can launch in 6 weeks with 95% of patients submitting all core endpoint data
- +5 more outcomes
Companies that use Curebase
Customer profileNamed customers11 records
Segments6 records
Ideal customer profiles5 records
Curebase technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature5 records
Curebase partnerships and signals
Strategic signalScale indicators7 records
Recent moves6 records
Expansion highlights6 records
Curebase competitors and assessment
Company assessmentBroad incumbents
- Medidata (Dassault Systèmes): Industry-leading eClinical platform offering EDC, eCOA, eConsent, CTMS, and RTSM as part of the broader Dassault Systèmes life sciences portfolio. Curebase's most direct large-enterprise competitor in the same buyer set.
- Veeva Systems: Enterprise cloud software provider for life sciences, including Veeva Vault CTMS, Vault EDC, ePRO, and eConsent. Competes with Curebase in large pharma for global trial platform standardization.
- Clario: Broad clinical trial technology and endpoints company offering EDC, eCOA, imaging, and cardiac safety solutions. Larger incumbent competing for enterprise eClinical RFPs alongside Curebase.
- Oracle Health Sciences (Clinical One): Oracle's unified eClinical platform (formerly goBalto/Clinical One) covering EDC, RTSM, ePRO, and CTMS. Enterprise-scale incumbent competing for global pharma standardization deals.
- IQVIA: Largest CRO with a broad eClinical technology stack and DCT capabilities through the IQVIA Decentralized Trials platform. Competes with Curebase both as a CRO partner and as a technology provider to sponsors.
Direct peers
- Medable: Decentralized clinical trial platform offering eCOA, eConsent, telehealth, and patient engagement for sponsors and CROs. Direct competitor in the DCT and modular eClinical space targeted at the same biotech/pharma buyer segments.
- Science 37: Decentralized clinical trial technology and operating company focused on bringing trials directly to patients' homes. Overlaps with Curebase's decentralized trial capabilities and sponsor-centric GTM.
- Castor: Cloud-based EDC and eClinical platform with strong adoption among emerging biotech and academic sponsors. Competes head-to-head with Curebase in the emerging biotech and modular-pricing segments.
- Signant Health: Provides eCOA, eConsent, patient engagement, and clinical supply chain solutions for clinical trials. Direct overlap with Curebase's ePRO/eCOA, eConsent, and engagement modules across pharma and biotech.
- THREAD Research: Decentralized clinical trial platform supporting eCOA, eConsent, virtual visits, and patient engagement. Competes with Curebase in DCT deployments for mid-market biotech and pharma.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Curebase social profiles
Digital presenceCurebase compliance and trust
Trust signalCompliance7 records
Curebase financial estimates
Financial estimateRevenue estimate
Valuation estimate
Curebase leadership team
Management profileNumber of profiles
Profiles10 records
Curebase subsidiaries and ownership
Company hierarchySubsidiaries1 record
Curebase funding detail
Funding detailFunding overview
Funding rounds5 records
Investors16 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Curebase M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Curebase
What does Curebase do?
Curebase provides a paid, end-to-end AI-native eClinical platform that helps clinical trial sponsors, CROs, biotechs, and MedTech companies launch studies faster, capture higher-quality data, and improve participant engagement across the full trial lifecycle (ePRO/eCOA, eConsent, EDC, recruitment, and engagement). The company also offers Sitebase, a free eClinical suite providing CTMS, eISF, and eSource technology to research sites to reduce administrative burden and drive bottom-up platform adoption.
Is Curebase a public or private company?
Curebase is a private company. It is classified as venture growth investor backed and is currently operating.
When was Curebase founded?
Curebase was founded in 2017. It employs 11 to 50 people.
Where is Curebase based?
Curebase is headquartered in San Francisco, United States, in the North America region.
How does Curebase make money?
Two revenue lines are on record. Curebase eClinical Platform (Paid Subscription) is the primary driver. The others are sitebase (Free Tier).
Who are Curebase's main competitors?
Broad incumbents on record are Medidata (Dassault Systèmes), Veeva Systems, Clario, Oracle Health Sciences (Clinical One) and IQVIA. Direct peers are Medable, Science 37, Castor, Signant Health and THREAD Research.
Does Curebase have an API?
No public API is recorded for Curebase.
What industry is Curebase in?
Curebase's product category is eClinical Platform / Clinical Trial Technology. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACAOAA, Electronic Data Capture (EDC) Platforms. Its NAICS code is 54151 and its SIC code is 7372.